External NordiQC Assessment Reports

GenomeMe participates in the NordiQC international quality assessment testing program for clinical IHC. Access the individual NordiQC assessment reports for each of the antibodies tested:

ANTIGEN CLONE ASSESSMENT RUN #
Calretinin IHC523 Optimal 64 2022
CD15 IHC527 Optimal 61 2021
CD31 IHC031 Optimal 62 2021
CD56 IHC066 Optimal 61 2021, 64 2022
CDX-2 IHC302 Good 61 2021
Cytokeratin 5/6 IHC556 Good 63 2021
Estrogen Receptor IHC423 Optimal B32 2021, B33 2022
HER2/neu IHC042 Optimal B32 2021, B33 2022
MSH6 IHC026 Optimal 61 2021
p63 IHC063 Good 61 2021
PAX-8 IHC048 Optimal 62 2021, 64 2022
PMS2 IHC422 Good 62 2021
Progesterone Receptor IHC751 Optimal B31 2021, B33 2022